Newsroom
Sorted by: Latest
-
Leblon Delienne si unisce a LEXON per ampliare la presenza globale di BOW
PARIGI--(BUSINESS WIRE)--BOW (Brands of Wonder), il gruppo internazionale di marchi alla base del brand francese di design LEXON, oggi ha annunciato l'acquisizione di Leblon Delienne, lo studio di scultura francese celebre per aver trasformato icone di cultura pop in oggetti d'arte e design da collezione. L'iniziativa abbina la caratteristica maestria artigianale francese dello studio e collezioni su licenza con la portata internazionale e le competenze digitali di BOW. Juliette de Blegiers, ch...
-
Leblon Delienne wird Teil von BOW und ergänzt LEXON für eine stärkere internationale Präsenz
PARIS--(BUSINESS WIRE)--BOW (Brands of Wonder), die internationale Markengruppe hinter der französischen Designmarke LEXON, gab heute die Übernahme von Leblon Delienne bekannt. Das französische Bildhaueratelier ist dafür bekannt, Ikonen der Popkultur in Sammlerkunst und Designobjekte zu verwandeln. Die Übernahme verbindet die unverwechselbare französische Handwerkskunst und die Lizenzkollektionen des Ateliers mit der internationalen Reichweite und der digitalen Expertise von BOW. Juliette de Bl...
-
Leblon Delienne voegt zich bij LEXON van BOW om zijn wereldwijde armslag uit te breiden
PARIJS--(BUSINESS WIRE)--BOW (Brands of Wonder), de internationale merkgroep achter het Franse designmerk LEXON, maakte vandaag de overname bekend van Leblon Delienne, het Franse beeldenatelier dat bekend staat om iconen van de popcultuur te transformeren in kunst- en designvoorwerpen om te verzamelen. Deze zet koppelt het onderscheidende Franse vakmanschap van het atelier en de gelicentieerde collecties met BOW’s internationale armslag en digitale expertise. Juliette de Blegiers, die het bedri...
-
Leblon Delienne se incorpora a BOW junto a LEXON para ampliar su presencia internacional
PARÍS--(BUSINESS WIRE)--BOW (Brands of Wonder), el grupo internacional de marcas que agrupa a la firma francesa de diseño LEXON, anunció hoy la adquisición de Leblon Delienne, el taller francés de escultura conocido por convertir iconos de la cultura popular en piezas de arte y objetos de diseño coleccionables. La operación reúne la singular artesanía francesa y las colecciones bajo licencia de Leblon Delienne con la presencia internacional y la experiencia digital de BOW. Juliette de Blegiers,...
-
Cegid and Silae Join Forces to Create a European Leader in AI-Driven Business Technology
PARIS--(BUSINESS WIRE)--Cegid, an AI-driven European leader in cloud business management software for small and medium-sized businesses (SMBs), and accounting professionals, and Silae, France’s leading payroll and human resources platform, today announced their intention to merge. The combination will create a national technology champion and the leading European technology platform for businesses and their partners, helping them grow safely and efficiently with the support of a fully integrate...
-
Infinedi Expands Its Team
NEW YORK--(BUSINESS WIRE)--Infinedi Partners, LP (“Infinedi”), a private equity firm focused on founder-owned businesses, today announced key additions to its team: Rohan Arora has joined Infinedi as a Principal. Rohan is responsible for sourcing, leading, growing and exiting investments for Infinedi. He was most recently a Senior Vice President in the private equity vertical at H.I.G. Capital. Nitish Jindal has joined Infinedi as a Vice President. Nitish is responsible for sourcing, leading, g...
-
Albertsons® Companies, Inc. Appoints Meg Whitman as Executive Chair
BOISE, Idaho--(BUSINESS WIRE)--Meg Whitman has been appointed to the newly created role of Executive Chair of Albertsons Companies' Board of Directors....
-
Compass Pathways’ New 52-Week Topline Open-Label Data from Phase 3 COMP005 Trial Demonstrates Additional Benefit from Another COMP360 Dose in Part C Extending Durability Out to 1 Year
LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today the topline 52-week results (Part C) from its Phase 3 COMP005 trial of COMP360, a synthetic, proprietary formulation of psilocybin, for treatment-resistant depression (TRD) which further support COMP360’s differentiated profile and potential for long lasting benefit. The open-label Part C data demonst...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest US Equity Max Buffer UCITS ETF - December 08.09.2026 MDEC.LN IE0007FIJUO5 50,002.00 USD 1,425,803.26 28.515 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Large Cap Core AlphaDEX UCITS ETF 08.09.2026 FEXD.LN IE00BWTNMB87 451,437.00 USD 45,620,605.42 101.056 ...